Utilizing Rapid Molecular Tests (RMT/RIF) in Tuberculosis Drug-Sensitive/Resistant Discovery in Indonesia: A Pilot Study

  1. World Health Organization. Global Tuberculosis Reports. Geneva: World Health Organization; 2015.

  2. Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pengendalian Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia; 2011.

  3. Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2007. Jakarta: Kementerian Kesehatan Republik Indonesia; 2008.

  4. Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2010. Jakarta: Kementerian Kesehatan Republik Indonesia; 2010.

  5. Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2013. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013.

  6. World Health Organization. Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System: Policy Statement. Geneva: World Health Organization; 2011.

  7. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet. 2011; 377 (9776): 1495-1505.

  8. Rachow A, Zumla A, Heinrich N, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay-a clinical validation study. PLoS One. 2011; 6 (6): e20458.

  9. Sekadde MP, Wobudeya E, Joloba ML, et al. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: A cross-sectional diagnostic study. BMC Infect Dis. 2013;13: 133.

  10. World Health Organization. Xpert MTB/RIF implementation manual: Technical and operational 'How-to': Practical Considerations. France: GPS Publishing; 2014.

  11. Menteri Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Nomor 67 Tahun 2016 Tentang Penanggulangan Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia; 2016.

  12. Directorate of P2PML Ministry of Health RI. Evaluation of P2TBC National Program Achievements and Strategies for Accelerating Achievement of National Targets. Jakarta; 2021.

  13. Dina Bisara dkk. (2018). Laporan “studi Evaluasi deteksi kasus TB dengan alat RMT di Indonesia tahun 2018’, 2018. Jakarta.

  14. Dougherty C. Introduction to econometrics. 2nd ed. New York: Oxford University Press; 2002.

  15. Ghozali I. Aplikasi Analisis Multivariate dengan Program IBM SPSS23. 8th ed. Semarang: Badan Penerbit Universitas Diponegoro; 2016.

  16. Sazkiah ER, Hardja BAR. Distribusi Penyakit Tuberkulosis Berdasarkan Jenis Kelamin dan Usia di Rumah Sakit Sri Pamela. BerKedokt Masy. 2018; 34 (11).

  17. Herawati MH. Alternatif Penanggulangan Tuberkulosis (TBC) Wilayah Indonesia di Luar Sumatra dan Jawa-Bali. Jakarta: LIPI Press; 2021.

  18. Herawati MH. Model Evaluasi Program Pengendalian TB di Indonesia (Data Rifaskes dan Data Program TB) [Dissertation]. Depok: Universitas Indonesia; 2016.

  19. Putri D, Miliyani S. Kegagalan Penjaringan Suspek Tuberkulosis Parupada P2TB Puskesmas di Kabupaten Jember Tahun 2015. Jember: Universitas Jember; 2017.

留言 (0)

沒有登入
gif